We are live on !
Find out more
Marshall & Sullivan Portfolio holdings
AUM
$216M
Turnover
63.87%
1-Year Est. Return
12.97%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+99.76%
10 Year Est. Return
+295.36%
AUM
$82.2M
AUM Growth
+$4.44M
(+5.7%)
Cap. Flow
+$5.34M
Cap. Flow % of AUM
Cap. Flow %
6.5%
Top 10 Holdings %
Top 10 Hldgs %
45.53%
Holding
58
New
2
Increased
10
Reduced
24
Closed
3
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Bank ETF
KBE
|
+$6.25M |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.74M |
| 3 |
Gilead Sciences
GILD
|
+$49.2K |
| 4 |
Danaher
DHR
|
+$30.6K |
| 5 |
Stericycle Inc
SRCL
|
+$16.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.21M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$56.9K |
| 3 |
La Quinta Holdings Inc.
LQ
|
+$55K |
| 4 |
Mastercard
MA
|
+$50.7K |
| 5 |
Fiserv Inc
FISV
|
+$47.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.65% |
| 2 | Consumer Staples | 15.68% |
| 3 | Technology | 13.62% |
| 4 | Consumer Discretionary | 12.69% |
| 5 | Miscellaneous | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P Bank ETF
KBE
$1.44B
| $7.04M | 8.56% |
+161,924
| New | +$6.25M |
2016 Q4
0 quarters
|
|
|
2
Fiserv Inc
FISV
$26.6B
| $4.08M | 4.96% |
76,730
-930
| -1% | -$47.8K |
2013 Q2
14 quarters
|
|
3
Stryker
SYK
$112B
| $3.62M | 4.4% |
30,201
-381
| -1% | -$43.8K |
2013 Q2
14 quarters
|
|
4
Home Depot
HD
$328B
| $3.59M | 4.37% |
26,781
-211
| -0.8% | -$27.2K |
2013 Q3
13 quarters
|
|
5
DELISTED
Walgreens Boots Alliance
WBA
| $3.34M | 4.06% |
40,343
-254
| -0.6% | -$21K |
2013 Q2
14 quarters
|
|
6
Becton Dickinson
BDX
$53.9B
| $3.32M | 4.04% |
20,591
-213
| -1% | -$35.4K |
2013 Q2
14 quarters
|
|
7
Church & Dwight Co
CHD
$25.3B
| $3.32M | 4.04% |
75,260
-262
| -0.3% | -$11.9K |
2013 Q2
14 quarters
|
|
8
Johnson & Johnson
JNJ
$658B
| $3.19M | 3.88% |
27,690
+52
| +0.2% | +$6.01K |
2013 Q2
14 quarters
|
|
9
PepsiCo
PEP
$187B
| $3.03M | 3.68% |
28,951
-75
| -0.3% | -$7.85K |
2013 Q2
14 quarters
|
|
10
RTX Corp
RTX
$270B
| $2.9M | 3.53% |
42,120
+239
| +0.6% | +$15.8K |
2013 Q2
14 quarters
|
|
11
Cognizant
CTSH
$29.1B
| $2.86M | 3.48% |
51,032
-134
| -0.3% | -$7.17K |
2013 Q2
14 quarters
|
|
12
Crown Holdings
CCK
$12.9B
| $2.85M | 3.46% |
54,164
-247
| -0.5% | -$13.4K |
2013 Q2
14 quarters
|
|
13
Alphabet (Google) Class A
GOOGL
$3.44T
| $2.8M | 3.4% |
70,580
-100
| -0.1% | -$4K |
2015 Q3
5 quarters
|
|
|
14
Danaher
DHR
$163B
| $2.73M | 3.32% |
39,579
+441
| +1% | +$30.6K |
2013 Q2
14 quarters
|
|
15
Colgate-Palmolive
CL
$75.7B
| $2.71M | 3.29% |
41,353
+114
| +0.3% | +$7.82K |
2013 Q2
14 quarters
|
|
16
DELISTED
Praxair Inc
PX
| $2.59M | 3.15% |
22,079
+136
| +0.6% | +$16.2K |
2013 Q2
14 quarters
|
|
|
17
Meta Platforms (Facebook)
META
$1.6T
| $2.57M | 3.12% |
+22,335
| New | +$2.74M |
2016 Q4
0 quarters
|
|
|
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
| $2.54M | 3.09% |
36,920
+131
| +0.4% | +$9.39K |
2013 Q2
14 quarters
|
|
19
Booking.com
BKNG
$111B
| $2.02M | 2.45% |
34,400
-625
| -2% | -$37.3K |
2013 Q2
14 quarters
|
|
|
20
Mastercard
MA
$556B
| $1.91M | 2.32% |
18,508
-490
| -3% | -$50.7K |
2013 Q2
14 quarters
|
|
21
Thermo Fisher Scientific
TMO
$258B
| $1.88M | 2.28% |
13,303
-183
| -1% | -$27K |
2013 Q2
14 quarters
|
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $1.78M | 2.17% |
15,406
-123
| -0.8% | -$13.7K |
2013 Q2
14 quarters
|
|
23
Monster Beverage
MNST
$92.7B
| $1.75M | 2.13% |
157,764
-396
| -0.3% | -$4.53K |
2013 Q2
14 quarters
|
|
|
WWAV
24
DELISTED
The WhiteWave Foods Company
WWAV
| $1.74M | 2.11% |
31,217
-790
| -2% | -$43.2K |
2016 Q1
3 quarters
|
|
|
25
Gilead Sciences
GILD
$212B
| $1.37M | 1.66% |
19,082
+662
| +4% | +$49.2K |
2013 Q2
14 quarters
|
|
Similar funds
Marshall & Sullivan's Q4 2016 Portfolio in Review
As of Q4 2016, Marshall & Sullivan held 58 positions worth $82.2M, up 5.7% from $77.8M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Marshall & Sullivan deployed $5.34M of net new capital in Q4 2016, opening 2 new positions and adding to 10 existing holdings. Its largest new stake was State Street SPDR S&P Bank ETF: 161,924 shares worth $7.04M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Apple, an estimated $3.21M trimmed.
- Marshall & Sullivan's largest Q4 2016 buy was State Street SPDR S&P Bank ETF: 161,924 shares worth $7.04M.
- Marshall & Sullivan added most to Gilead Sciences in Q4 2016, an estimated $49.2K increase.
- Marshall & Sullivan's biggest Q4 2016 reduction was Apple, cutting an estimated $3.21M.
- Marshall & Sullivan fully exited La Quinta Holdings Inc. in Q4 2016, selling an estimated $55K.
- Marshall & Sullivan's ten largest holdings make up 46% of its $82.2M portfolio in Q4 2016.
- Marshall & Sullivan opened 2 new positions and closed 3 in Q4 2016.
- Marshall & Sullivan's portfolio value rose 5.7% quarter-over-quarter to $82.2M.
Based on Marshall & Sullivan's 13F filing for Q4 2016, filed 13 Feb 2017.